Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 991 | 139 | 0.1872 | 0.1689 | 0.1403 | 0.1617 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 645 | 111 | 0.1173 | 0.1689 | 0.1721 | 0.1617 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1571 | 537 | 0.3278 | 0.3216 | 0.3418 | 0.3331 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1912 | 646 | 0.4014 | 0.3216 | 0.3379 | 0.3331 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2098 | 334 | 0.0923 | 0.0842 | 0.1592 | 0.1524 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1093 | 1032 | 0.0087 | 0.0084 | 0.9442 | 0.9531 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3381 | 232 | 0.1648 | 0.1538 | 0.0686 | 0.0753 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1135 | 1078 | 0.0081 | 0.0064 | 0.9498 | 0.9579 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1681 | 1503 | 0.0254 | 0.0314 | 0.8941 | 0.8595 |
WM-115 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 2072 | 591 | 0.3540 | 0.3601 | 0.2852 | 0.2576 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1560 | 1386 | 0.0249 | 0.0314 | 0.8885 | 0.8595 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1509 | 1201 | 0.0440 | 0.0314 | 0.7959 | 0.8595 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1275 | 1218 | 0.0081 | 0.0084 | 0.9553 | 0.9531 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 937 | 901 | 0.0051 | 0.0064 | 0.9616 | 0.9579 |
WM-115 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1606 | 522 | 0.2591 | 0.2721 | 0.3250 | 0.3045 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 921 | 884 | 0.0044 | 0.0047 | 0.9598 | 0.9535 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1083 | 877 | 0.0342 | 0.0290 | 0.8098 | 0.8526 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1440 | 1382 | 0.0083 | 0.0084 | 0.9597 | 0.9531 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1090 | 1049 | 0.0059 | 0.0064 | 0.9624 | 0.9579 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1051 | 926 | 0.0207 | 0.0290 | 0.8811 | 0.8526 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1553 | 1428 | 0.0207 | 0.0156 | 0.9195 | 0.9257 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1247 | 1183 | 0.0091 | 0.0097 | 0.9487 | 0.9430 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 3 | 954 | 881 | 0.0121 | 0.0156 | 0.9235 | 0.9257 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 446 | 136 | 0.0983 | 0.1027 | 0.3049 | 0.2808 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 1 | 526 | 138 | 0.1230 | 0.1027 | 0.2624 | 0.2808 |